As expected, the proportion of MLH1 and PMS2 deficiency in the high ACE2 group was higher than that in the low ACE2 group, which indicated that BC patients with high ACE2 expression might have a high MSI-H proportion (Fig. 2F). The gene discussed is ACE2; the disease is breast cancer.